Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate-mefloquine for Schistosomiasis in Children
NCT03893097Phase 3Completed
- Sponsor
- Institute of Tropical Medicine Antwerp
- Start
- Oct 2019
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of artesunate + mefloquine in schistosomiasis, sponsored by Institute of Tropical Medicine Antwerp. Started Oct 2019; status: completed.
02
Drugs
artesunate + mefloquine
03
Conditions
schistosomiasis
Beyond the preview
Go deeper on NCT03893097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03893097.